ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Succinic Acid Firms Strike Royalty Deal

by Alex Scott
January 18, 2016 | APPEARED IN VOLUME 94, ISSUE 3

The succinic acid maker BioAmber has agreed to pay Reverdia royalties for the right to use certain intellectual property for making the biobased chemical. Reverdia is a joint venture between DSM and Roquette. The parties aren’t disclosing the technology in question or the amount of money that will change hands. The agreement is a “constructive solution” that avoids confrontation and enables both firms to continue to use their own yeast-based routes to succinic acid, says BioAmber CEO Jean-François Huc.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment